Class Actions

Amberen Menopause Pill Investigation

Wasserman, Comden, Casselman & Esensten L.L.P. is currently investigating whether claims by the manufacturers and distributors of the menopause symptom relief product, Amberen, are false and constitute illegal labeling.

The product is advertised to consumers as having been "clinically tested and extensively studied for over 30 years." The sellers claim that Amberen "contains patent-pending smart molecules that boost the body's hormonal function;" provides "fast and lasting" relief for "symptoms of menopause;" and "restores energy metabolism to youthful levels, supporting optimal function of vital organs and tissues."

Users of the product are instructed to "take just 2 capsules a day for 90 days." The effects of Amberen are purported to last, on average, for up to 3 months after users complete their course.

Lunada Biomedical , the makers of Amberen, offer a "risk free" 30-day supply of the product at no cost to the consumer. An investigation is underway as to whether these claims are accurate and whether the free 30-day trial is always provided.

If you or someone you know has purchased Amberen and 1) did not experience the advertised results; 2) could not obtain a refund; and/or 3) had unauthorized funds taken from a credit or debit account, please contact Wasserman, Comden, Casselman & Esensten, L.L.P.